In the fourth and final part of the series, Daniel Mackiewicz, a multi-skilled operator of sterile manufacturing at GSK Boronia, reflects on how the company has been determined to 'finish strong' as it works towards exiting the site it has occupied for 52 years.
GSK Boronia and the focus on 'finishing strong' for patients
December 14, 2022 Latest NewsBioPharmaBioPharmaDispatch ExecutiveNews of the DayLatest Video
New Stories
-
President's nominee denies calling for seizure of pharmaceutical patents
January 30, 2025 - - Latest News -
GPs call on NSW Government to fund free Meningococcal B vaccine
January 30, 2025 - - Latest News -
New Zealand's Pharmac reconsiders proposed move to single oestradiol patch brand
January 30, 2025 - - Latest News -
QBiotics strengthens medical leadership with two senior appointments
January 28, 2025 - - Australian Biotech -
Chemist Warehouse reports strong sales and earnings growth with merger to progress
January 28, 2025 - - Latest News -
Trapped arguing for changes that won't make a meaningful difference
January 28, 2025 - - Latest News -
Medicines Australia wants progress on 'immediate impact' recommendations
January 28, 2025 - - Latest News